Dental Tribune India
EDITION
INDIA
CORONAVIRUS
LIVE UPDATES
New ICMR study says with an excellent specificity and moderate sensitivity, this RAT may be used to 'rule in' COVID-19 in patients with a duration of illness ≤5 days. (Photo: PIXNIO)
New ICMR study: Rapid Antigen Test can detect COVID-19 patients within the first 5 days of illness
Back to news India
By Rajeev Chitguppi, Dental Tribune South Asia
November 09, 2020
Rapid Antigen Test (RAT) showed an excellent specificity to 'rule-in' COVID-19 patients within the first 5 days of illness and had a moderate sensitivity. Therefore, patients showing positive results need to be immediately triaged and those with negative tests should be reconfirmed by an rRT-PCR.
The problem with the real-time reverse transcription-polymerase chain reaction (rRT-PCR) testing is that it requires a sophisticated Biosafety level (BSL)-2/BSL3 laboratory setup, and also trained technicians to run the test and interpret results. It takes a minimum of 8-10 h for the rRT-PCR from swab collection until the results are reported.
This duration can increase further in resource-limited and high-burden settings, eg. in small towns and cities, where molecular diagnostic laboratories are non-existent, and where they find it difficult to procure the reagents/ viral transport medium (VTM) and other resources. Therefore, the need of the hour is to rapidly detect and isolate positive cases to contain the disease spread, to quickly triage patients with severe acute respiratory illness (SARI) in emergency departments (EDs) and to ramp up testing facilities.
Many Rapid Antigen Test (RAT) - kits and devices are available/ being developed to facilitate point-of-care testing. However, there is very limited data on the performance and potential diagnostic utility of a rapid chromatographic immunoassay-based antigen test for SARS-CoV-2 in suspected patients.
A cross-sectional, single-blinded study was conducted at a tertiary care teaching hospital in north India. Paired samples were taken for RAT and rRT-PCR (reference standard) from consecutive participants screened for COVID-19 to calculate the sensitivity and specificity of the RAT. Further sub-group analysis was done based on the duration of illness and cycle threshold values.
Results:
Of the 330 participants, 77 were rRT-PCR positive for SARS-CoV-2. 64 out of these 77 patients
also tested positive for SARS-CoV-2 by RAT. The overall sensitivity and specificity were 81.8 and 99.6
per cent, respectively.
Overall, among the positive test results, with respect to the reference standard, the RAT detected 63 true-positives (19%) and gave one false-positive result. Among the negative test results, 252 (76.3%) were true- negatives and 14 (4.2%) were false-negatives.
What is significant in this study?
The overall sensitivity of the test was 81.8% and specificity was 99.6 %. The test accuracy was 95.4 %. But the sensitivity of RAT was higher (85.9%) in participants with a duration of illness ≤5 days.
The RAT in the present study showed a high positive Likelihood Ratio (LR) of 207.0, which indicates a 207-fold increase in the odds of having infection with SARS-CoV-2 in participants with positive RDT results.
Likewise, the negative LR for the RAT was 0.18, which means that the odds of having SARS-CoV-2 infection had decreased by 5.5-fold after a negative RDT result.
Conclusion:
With an excellent specificity and moderate sensitivity, this RAT may be used to 'rule in' COVID-19 in patients with a duration of illness ≤5 days. Large-scale testing based on this RAT across the country would result in quick detection, isolation and treatment of COVID-19 patients.
Reference:
Gupta A, Khurana S, Das R, Srigyan D, Singh A, Mittal A, Singh P, Soneja M, Kumar A, Singh AK, Soni KD, Meena S, Aggarwal R, Sharad N, Aggarwal A, Kadnur H, George N, Singh K, Desai D, Trilangi P, Khan AR, Kiro VV, Naik S, Arunan B, Goel S, Patidar D, Lathwal A, Dar L, Trikha A, Pandey RM, Malhotra R, Guleria R, Mathur P, Wig N.
Rapid chromatographic immunoassay-based evaluation of COVID-19: A cross-sectional, diagnostic test accuracy study & its implications for COVID-19 management in India.
Indian J Med Res. 2020 Oct 31.
doi: 10.4103/ijmr.IJMR_3305_20.
Epub ahead of print. PMID: 33146157.
Pubmed: https://pubmed.ncbi.nlm.nih.gov/33146157/
Leave a Reply
Your email address will not be published. Required fields are marked *
Comment
Name *
Email *
Website
advertisement
Content you may be interested in:
November 8, 2020 | News
ICMR replies to dentist’s letter on the use of Rapid Antigen Tests for Covid-19 in dental clinics
Rapid Antigen Tests are an easy and economical option for dentists to use in their clinics to identify the potential Covid-19 spreaders visiting their dental clinics. However, these tests are not available for dentists. A letter that was sent to health authorities and ICMR on 17 Sept 2020 has finally received a response on 1 Nov 2020. Read the ICMR responses below.
May 2, 2020 | News
US FDA grants Emergency Use Authorization (EUA) for the antiviral drug Remdesivir to treat COVID-19
The US Food and Drug Administration has granted 'Emergency Use Authorization (EUA)' for Gilead Sciences’ antiviral drug remdesivir to treat COVID-19, the disease caused by the coronavirus. Remdesivir is now the first authorized therapy drug for COVID-19.
March 28, 2020 | News
Very few dental clinics continue to operate in Italy, work restricted to emergency dental care.
MILAN, Italy: Italy has become the European country worst affected by the COVID-19 outbreak, its confirmed cases of infection currently reaching 74,386, according to the World Health Organization (WHO). As the country is facing a nationwide lockdown, the pandemic has completely reshaped people’s daily lives, weakened the economy and boosted unemployment rates. To minimise the risks associated with contagion and slow down the spread, the Italian prime minister, Giuseppe Conte, has recently ordered the shutdown of all non-essential factories and businesses. In the meantime, some dental offices continue to operate, offering patients emergency care only.
March 21, 2020 | News
COVID-19: Canadian Dental Association says situation is changing rapidly
OTTAWA, Ontario, Canada: The COVID-19 pandemic has resulted in dental practices across Canada being told to delay elective and preventive treatments, and the Canadian Dental Association (CDA) has told Dental Tribune International that the situation remains fluid. While some dental practices remain open, the CDA says that this could change at any moment, based on, but not limited to, the directives and recommendations that are being issued by provincial dental regulatory authorities.
INTERNATIONAL
AMERICAS
Brazil / Brasil
Canada / Canada
Latin America / Latinoamérica
USA / USA
EUROPE
Austria / Österreich
Belgium (Flemish) / België
Belgium (French) / Belgique
Bosnia and Herzegovina / Босна и Херцеговина
Bulgaria / България
Croatia / Hrvatska
Czech Republic & Slovakia / Česká republika & Slovensko
Denmark / Danmark
Finland / Suomi
France / France
Germany / Deutschland
Greece / ΕΛΛΑΔΑ
Israel / ישראל
Italy / Italia
Netherlands / Nederland
Norway / Norge
Poland / Polska
Romania & Moldova / România & Moldova
Russia / Россия
Serbia & Montenegro / Србија и Црна Гора
Slovenia / Slovenija
Spain / España
Switzerland / Schweiz
Turkey / Türkiye
UK & Ireland / UK & Ireland
ASIA PACIFIC
China / 中国
India / भारत गणराज्य
Iran / ایران
Japan / 日本
Pakistan / Pākistān
MIDDLE EAST & AFRICA
Algeria / الجزائر
Middle East / Middle East
Publisher Advertise with us Contact Terms & Conditions Imprint Privacy Policy
© 2020 - All rights reserved - Dental Tribune International
